Zobrazeno 1 - 10
of 27
pro vyhledávání: '"R. C. Reichman"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 34:394-397
The disposition of zidovudine (ZDV) was examined during chronic oral dosing (300 mg every 4 h while awake) for 12 weeks in eight asymptomatic patients with hemophilia who were infected with the human immunodeficiency virus. Pharmacokinetic studies we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaa44f850fba3a20bbf19f77e5bcf95e
https://doi.org/10.1128/aac.34.3.394
https://doi.org/10.1128/aac.34.3.394
Autor:
G D, Morse, R C, Reichman, M A, Fischl, M, Para, J, Leedom, W, Powderly, L M, Demeter, L, Resnick, Y, Bassiakos, J, Timpone, S, Cox, D, Batts
Publikováno v:
Antiviral research. 45(1)
To determine the dosage requirements and pharmacokinetics of atevirdine, a non-nucleoside reverse transcriptase inhibitor and its N-dealkylated metabolite (N-ATV) during phase I studies in patients receiving atevirdine alone or in combination with zi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::61c918fbc9dd9017be7f2ec8656d7e6e
https://pubmed.ncbi.nlm.nih.gov/10774589
https://pubmed.ncbi.nlm.nih.gov/10774589
Autor:
C A, Benson, P L, Williams, D L, Cohn, S, Becker, P, Hojczyk, T, Nevin, J A, Korvick, L, Heifets, C C, Child, M M, Lederman, R C, Reichman, W G, Powderly, G F, Notario, B A, Wynne, R, Hafner
Publikováno v:
The Journal of infectious diseases. 181(4)
The efficacy and safety of clarithromycin and rifabutin alone and in combination for prevention of Mycobacterium avium complex (MAC) disease were compared in 1178 patients with AIDS who hador =100 CD4 T cells/microL in a randomized, double-blind, pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e76c4fcce9782af1b3f9111c199548a8
https://pubmed.ncbi.nlm.nih.gov/10762562
https://pubmed.ncbi.nlm.nih.gov/10762562
Autor:
A C, Collier, R W, Coombs, D A, Schoenfeld, R L, Bassett, J, Timpone, A, Baruch, M, Jones, K, Facey, C, Whitacre, V J, McAuliffe, H M, Friedman, T C, Merigan, R C, Reichman, C, Hooper, L, Corey
Publikováno v:
The New England journal of medicine. 334(16)
In patients with human immunodeficiency virus (HIV) infection, combined treatment with several agents may increase the effectiveness of antiviral therapy. We studied the safety and efficacy of saquinavir, an HIV-protease inhibitor, given with one or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7e273511dc1720042383f88c24f814bd
https://pubmed.ncbi.nlm.nih.gov/8598838
https://pubmed.ncbi.nlm.nih.gov/8598838
Publikováno v:
Archives of internal medicine. 156(3)
Much controversy exists concerning the manifestations, therapy, and response to treatment of syphilis in patients coinfected with the human immunodeficiency virus (HIV).To assess the effect of HIV infection on the serologic response to treatment of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3a9c3b001740020af65b5fdb9ee305cc
https://pubmed.ncbi.nlm.nih.gov/8572843
https://pubmed.ncbi.nlm.nih.gov/8572843
Autor:
R C, Reichman, G D, Morse, L M, Demeter, L, Resnick, Y, Bassiakos, M, Fischl, M, Para, W, Powderly, J, Leedom, C, Greisberger
Publikováno v:
The Journal of infectious diseases. 171(2)
Twenty patients were enrolled in a phase I clinical trial of atevirdine, a nonnucleoside reverse transcriptase inhibitor (NNRTI), given in combination with zidovudine for treatment of human immunodeficiency virus type 1 (HIV-1) infection. Fifteen pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a6f8444932a666b89bf8d1a589fd008f
https://pubmed.ncbi.nlm.nih.gov/7531207
https://pubmed.ncbi.nlm.nih.gov/7531207
Publikováno v:
Pharmacotherapy. 14(6)
To determine the effect of a high-fat breakfast on single-dose, zidovudine (ZDV) pharmacokinetics.Open-label, randomized, crossover study.Eighteen asymptomatic subjects (12 men, 6 women) infected with the human immunodeficiency virus (mean CD4 cell c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5bf84e15e93ab8cf6df651ce623e6a9
https://pubmed.ncbi.nlm.nih.gov/7885970
https://pubmed.ncbi.nlm.nih.gov/7885970
Autor:
P A, Volberding, S W, Lagakos, J M, Grimes, D S, Stein, H H, Balfour, R C, Reichman, J A, Bartlett, M S, Hirsch, J P, Phair, R T, Mitsuyasu
Publikováno v:
JAMA. 272(6)
To determine the durability of zidovudine-induced delay in clinical progression of asymptomatic human immunodeficiency virus (HIV) disease and to assess the relationship between this effect and the entry CD4+ cell count.Extended follow-up data from s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d77df5f340ffb347acac602b80d6e4f2
https://pubmed.ncbi.nlm.nih.gov/7913730
https://pubmed.ncbi.nlm.nih.gov/7913730
Publikováno v:
The Journal of infectious diseases. 163(3)
The lymphocyte proliferative responses were studied of 12 volunteers enrolled in a phase I trial of a baculovirus-expressed recombinant human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (rgp160) vaccine. Six subjects received rgp160 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::02108802612d97ddf1a00e3dfecec4fa
https://pubmed.ncbi.nlm.nih.gov/1995718
https://pubmed.ncbi.nlm.nih.gov/1995718
Autor:
R, Dolin, J S, Lambert, G D, Morse, R C, Reichman, C S, Plank, J, Reid, C, Knupp, C, McLaren, C, Pettinelli
Publikováno v:
Reviews of infectious diseases. 12
Twenty-one patients with AIDS or AIDS-related complex (ARC) received 2',3'-dideoxyinosine (didanosine; ddI) intravenously and then orally (initial dosages of 0.4 mg/kg and 0.8 mg/kg every 12 hours, respectively) for 6-44 weeks in an escalating-dose s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::051d8a274e85fa5d07e8bd3fa46879ff
https://pubmed.ncbi.nlm.nih.gov/1974726
https://pubmed.ncbi.nlm.nih.gov/1974726